Emami Limited has delivered exceptional financial performance in Q3FY26, reporting consolidated net sales of ₹1,147 crore compared to ₹1,036 crore in the corresponding quarter of the previous year. The consumer goods company achieved consolidated net profit of ₹319 crore, marking a significant 15% increase from ₹279 crore in the same period last year.

Outstanding Financial Performance

The company's quarterly results demonstrate robust growth across all key financial metrics. Net sales growth of 11% year-on-year, combined with the 15% increase in net profit, showcases Emami's ability to drive both top-line and bottom-line expansion. The company reported EBITDA of ₹384 crore, representing a substantial 13% increase from ₹339 crore in the corresponding quarter of the previous year.

Exceptional Margin Expansion

Emami's EBITDA margin improved significantly to 33.4% in Q3FY26, compared to 32.3% in the same period last year, reflecting enhanced operational efficiency and superior cost management. This margin expansion of 110 basis points demonstrates the company's ability to optimize its cost structure while maintaining strong growth momentum across its business operations. Gross margins also expanded to 70.6%, an improvement of 30 basis points.

Strong Domestic and International Performance

The domestic business delivered growth of 11%, driven by robust volume growth of 9%. All major brands registered healthy performance during the quarter, with BoroPlus Range leading growth at 16%, followed by Kesh King Range at 10%, Pain Management Range at 8%, and Healthcare Range at 7%. The international business recorded sales growth of 9%, contributing 15% to overall sales, with strong performance across SAARC, MENA, and CIS regions.

Strategic Innovation and Product Launches

During the quarter, Emami launched several new products including Kesh King Gold Advanced Hair Growth Serum, BoroPlus Deeply Moisturising Lip Balm, Zandu Apple Cider Vinegar Effervescent Tablets, and Zandu Good Gut Constipation Relief Tablets. The Man Company introduced Vitamin C and Anti Acne Facewash, Moisturizing Gel Cream, and Anti Dandruff Shampoo, further strengthening its premium male grooming segment.

Regulatory Compliance and Publication

Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Emami Limited published its unaudited financial results for the quarter and nine months ended December 31, 2025, in newspapers. The results were published in "Business Standard" (English Version) and "Aajkal" (Bengali Version) on February 5, 2026, following Board approval on February 4, 2026.

Interim Dividend Declaration

The Board of Directors declared a second interim dividend of 600%, amounting to ₹6 per share for FY26. With this declaration, the total dividend for the nine months ended FY26 stands at ₹10 per share, demonstrating the company's confidence in its financial strength and commitment to rewarding shareholders.

Source: Emami Limited Investor Presentation Q3FY26, Business Standard newspaper publication

Emami Limited has announced that its Board of Directors will convene on February 4, 2026, to deliberate on the company's third-quarter financial performance and potential dividend distribution. Additionally, the company will host an investor conference call on the same day to discuss business strategy and outlook following the results announcement.

Board Meeting Agenda

The board meeting will focus on two primary agenda items that are crucial for shareholders and market participants:

The company will review its unaudited standalone and consolidated financial results for the quarter ended December 31, 2025. Additionally, the board will deliberate on the declaration of a second interim dividend for the financial year 2025-26, though the final decision remains subject to board approval.

Investor Conference Call Details

Following the board meeting, Emami Limited will conduct a conference call with analysts and investors to discuss the quarterly results and business outlook:

Management Participation

The conference call will feature key management personnel who will provide insights into the company's performance and strategic direction:

Trading Window Restrictions

Emami Limited has implemented trading window restrictions in accordance with insider trading regulations:

The extended closure period ensures compliance with regulatory requirements surrounding the announcement of quarterly financial results and potential dividend declarations.

Regulatory Compliance

Both announcements were made pursuant to SEBI regulations - the board meeting under Regulation 29 and the conference call under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. These regulations mandate listed companies to inform stock exchanges about significant corporate developments.

Emami Limited's Company Secretary and Compliance Officer, Ravi Varma, signed the official communications to both NSE and BSE on January 7, 2026. The company maintains transparency with market participants by providing advance notice of significant corporate developments that may impact investor decisions.